Gabelli Funds’s Astria Therapeutics ATXS Stock Holding History

Gabelli Funds’s Portfolio ATXS Stock Details ATXS Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q1	–	Sell	-401,450	Closed	-$5.25M	–	1268
2025 Q4	$5.25M	Buy	+401,450	New	+$4.79M	0.04%	483

Gabelli Funds's ATXS Position: Q1 2026 in Review

Gabelli Funds sold out of Astria Therapeutics (ATXS) in Q1 2026, closing a stake of 401,450 shares — an estimated $5.25M sold.

Gabelli Funds first reported a position in ATXS in Q4 2025 and held it in 1 quarter. The position peaked at $5.25M in Q4 2025. 0 funds tracked by Wall St. Rank hold ATXS as of Q1 2026.

Gabelli Funds reported no remaining Astria Therapeutics position as of Q1 2026 after selling out during the quarter.
Gabelli Funds sold 401,450 Astria Therapeutics shares in Q1 2026, an estimated $5.25M.
Gabelli Funds first reported a position in Astria Therapeutics in Q4 2025 and held it in 1 quarter.
Gabelli Funds's Astria Therapeutics position peaked at $5.25M in Q4 2025.
0 funds tracked by Wall St. Rank held Astria Therapeutics as of Q1 2026.

Based on Gabelli Funds's 13F filing for Q1 2026, filed 14 May 2026.